NEW YORK (GenomeWeb News) – Shares of Sequenom fell around 10 percent in Wednesday trade, a day after the firm released additional data from a study on its prenatal screening technology for Down syndrome.
Registering provides access to this and other free content.
Already have an account?Login Now.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.